Skip to content

Life Improvement Following Traumatic Brain Injury

Cognitive Behavioral Therapy for Depression After Traumatic Brain Injury

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00878150
Acronym
LIFT
Enrollment
100
Registered
2009-04-08
Start date
2007-09-30
Completion date
2013-09-30
Last updated
2013-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Traumatic Brain Injury

Keywords

traumatic brain injury, TBI, head injury, brain injury, depression, major depressive disorder, cognitive behavioral therapy, CBT, counseling

Brief summary

The purpose of this study is to test the effectiveness of a telephone-based and in-person Cognitive Behavioral Therapy (CBT) intervention for treating Major Depressive Disorder (MDD) following Traumatic Brain Injury. Participants are randomly assigned to receive one of the following: 1) Telephone-based CBT, 2) In-person CBT, or 3) Usual care (control).

Detailed description

Major Depressive Disorder (MDD) is the most prevalent psychiatric disorder in persons with traumatic brain injury (TBI) and is most common during the first several years after injury. MDD following TBI is associated with poor behavioral, health, and functional outcomes. While neurological factors contribute somewhat to the development of MDD in this population, there is evidence that numerous psychological, social and vocational factors also contribute. There are also multiple barriers to effective treatment of MDD in persons with TBI, including: * under-diagnosis and under-treatment 20lack of access to care due to mobility, transportation and health care benefit limitations * TBI neurocognitive impairments * comorbid medical and psychiatric problems, including substance abuse * stressors such as lack of social support and work instability * inaccurate beliefs about depression and its treatment among TBI survivors. The investigators are conducting a three arm trial of Cognitive Behavioral Therapy (CBT) to treat Major Depression Disorder (MDD) that emerges within the first 10 years after complicated mild to severe traumatic brain injury (TBI). The overall objective of the study is to develop a 12-session telephone-based and in-person CBT program for people with TBI (CBT-TBI), and to evaluate its feasibility, acceptability, and effectiveness. The investigators project aims are to 1. develop CBT for for Major Depression Disorder (MDD) in persons with TBI that can be delivered in-person or via the telephone 2. conduct a trial of CBT-TBI delivered either in-person or via telephone versus care as usual 3. refine the intervention and plan a definitive RCT of CBT-TBI if response rate is sufficient. Participants are randomized to one of three groups: (1) 12 semi-weekly sessions of telephone-based CBT for depression provided by a study therapist, (2) 12 semi-weekly sessions of in-person CBT for depression provided by a study therapist, or (3) Usual Care (control). Randomization is stratified by injury severity to ensure equal proportions in each treatment group. Participants choose one of three randomization options that includes the groups to which he/she would like to be randomized: * Option 1: Telephone counseling verses usual care * Option 2: In-person counseling verses usual care * Option 3: In-person counseling verses Telephone counseling verses usual care Outcomes are assessed by a blinded research assistant at 8, 16, and 24 weeks after baseline.

Interventions

BEHAVIORALIn-person Cognitive Behavioral Therapy

12 sessions of CBT delivered in-person over 16 weeks

12 sessions of telephone-based CBT over 16 weeks

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
U.S. Department of Education
CollaboratorFED
University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* hospitalized for TBI within the last 10 years, and at least one month post-injury * sustained a complicated mild to severe TBI as indicated by Glasgow Coma Scale score of 3-12 or had documented intracranial abnormalities on CT scan or had post-traumatic amnesia (PTA) of at least 7 days * meet screening criteria for major depression * speak English fluently * resides in any of the the 50 United States

Exclusion criteria

* does not have a telephone * does not have a stable address * history of bipolar disorder or schizophrenia, or current psychosis or suicidal intent * current alcohol or substance dependence (within last month) * evidence of significant cognitive impairment on neuropsychological testing * started on an antidepressant medication within 6 weeks or planning to start on an antidepressant within the 16-week study * currently in psychotherapy for depression or plan to start psychotherapy for depression within the 16-week study period * refusal to participate

Design outcomes

Primary

MeasureTime frame
Hamilton Rating Scale for Depression (HAM-D)16 weeks, 24 weeks
Symptom Checklist-20 (SCL-20)16 weeks, 24 weeks

Secondary

MeasureTime frame
Structured Clinical Interview for DSM-IV (SCID)- Current MDD only16 weeks, 24 weeks
Automatic Thoughts Questionnaire16 weeks
Dysfunctional Attitudes Scale16 weeks
Patient Health Questionnaire-9 (PHQ-9)16 weeks, 24 weeks
Medical Outcome Short Form- 36 (SF-36)16 weeks, 24 weeks
Sheehan Disability Scale16 weeks, 24 weeks
Environmental Reward Observation Scale (EROS)16 weeks
Head Injury Symptom Checklist16 weeks, 24 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026